Steven Weitman
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Oncology top 5%
- CAR-T cell therapy research
Papers in
-
- Cancer therapeutics and mechanisms 7
- Protein Degradation and Inhibitors 5
- Oncology 25
- Cancer Treatment and Pharmacology 7
- Co-authors
- Leslie R. Coney (2 shared papers)B A Kamen (5 shared papers)Daniel W. Fort (2 shared papers)Richard H. Lark (2 shared papers)V R Zurawski (1 shared paper)Verna Frasca (1 shared paper)Barton A. Kamen (4 shared papers)Vincent R. Zurawski (1 shared paper)
- Journals
- Journal of Clinical Oncology (21 papers)Cancer Chemotherapy and Pharmacology (7 papers)Journal of Pediatric Hematology/Oncology (7 papers)Anti-Cancer Drugs (6 papers)Investigational New Drugs (5 papers)
- Partner nations
- United StatesFrancePoland
In The Last Decade
Steven Weitman
92 papers receiving 3.0k citations
Steven Weitman's Hit Papers
Peers
Comparison fields: 5 of 135
- Biomaterials 444
- Oncology 722
- Hematology 298
- Rheumatology 266
- Genetics 162
Countries citing papers authored by Steven Weitman
This map shows the geographic impact of Steven Weitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Weitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Weitman more than expected).
Fields of papers citing papers by Steven Weitman
This network shows the impact of papers produced by Steven Weitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Weitman. The network helps show where Steven Weitman may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven Weitman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Hit paper breakdown → | 1992 | 889 |
| 2 | Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. | 1992 | 276 |
| 3 | 2006 | 215 | |
| 4 | 2012 | 180 | |
| 5 | 1994 | 100 | |
| 6 | 1993 | 98 | |
| 7 | 2002 | 85 | |
| 8 | 1993 | 73 | |
| 9 | 2017 | 73 | |
| 10 | Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies. | 2001 | 56 |
| 11 | 1998 | 53 | |
| 12 | 1982 | 50 | |
| 13 | 1998 | 44 | |
| 14 | 1998 | 39 | |
| 15 | 1999 | 37 | |
| 16 | 2018 | 35 | |
| 17 | 2002 | 34 | |
| 18 | A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group study. | 1999 | 34 |
| 19 | 2014 | 32 | |
| 20 | 1999 | 30 |
About Steven Weitman
Steven Weitman is a scholar working on Molecular Biology, Oncology, Genetics, Hematology and Public Health, Environmental and Occupational Health, having authored 95 papers that have together received 3.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (13 papers), Acute Myeloid Leukemia Research (8 papers), Cancer Treatment and Pharmacology (7 papers), Cancer therapeutics and mechanisms (7 papers), Acute Lymphoblastic Leukemia research (6 papers), Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Biomaterials (444 citations), Oncology (722 citations), Hematology (298 citations), Rheumatology (266 citations) and Genetics (162 citations). Steven Weitman has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Leslie R. Coney, B A Kamen, Daniel W. Fort, Richard H. Lark, V R Zurawski, Verna Frasca, Barton A. Kamen, Vincent R. Zurawski, Arthur G. Weinberg and Debra S. Jennings. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Journal of Pediatric Hematology/Oncology, Anti-Cancer Drugs and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.